| PULMATRIX INC. DL-,0001 |
| USA |
| Gesundheit |
| US74584P3010 / A3DWEE |
| 2PU (Frankfurt) / PULM (NASDAQ) |
| FRA:2PU, ETR:2PU, 2PU:GR, NASDAQ:PULM |
| - |
| https://www.pulmatrix.com.. |
|
Pulmatrix Inc. is a biotechnology company focused on the discovery and development of innovative inhaled therapies to address significant unmet needs in respiratory diseases. The company's primary fun..
>Volltext.. |
| 7.11 Mio. EUR |
| 3.63 Mio. EUR |
| - |
| -4.45 Mio. EUR |
| -4.45 Mio. EUR |
| -1.22 EUR |
| - |
| 3.52 Mio. EUR |
| -4.68 Mio. EUR |
| 12.43 |
| -100% |
| 52.4% |
| - |
| - |
| - |
| - |
| PULMATRIX |
| 26.03.26 |
|